UnitedHealth Group Incorporated (NYSE:UNH) is Bank Julius Baer & Co. Ltd Zurich’s 9th Largest Position

Bank Julius Baer & Co. Ltd Zurich increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 16.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,514,729 shares of the healthcare conglomerate’s stock after purchasing an additional 209,096 shares during the period. UnitedHealth Group makes up about 2.5% of Bank Julius Baer & Co. Ltd Zurich’s holdings, making the stock its 9th biggest holding. Bank Julius Baer & Co. Ltd Zurich’s holdings in UnitedHealth Group were worth $824,215,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $25,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at approximately $30,000. Promus Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $32,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group during the 3rd quarter valued at $37,000. Finally, DecisionPoint Financial LLC grew its holdings in UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after acquiring an additional 62 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Trading Up 1.2 %

NYSE:UNH opened at $493.35 on Friday. The company has a 50 day simple moving average of $513.78 and a two-hundred day simple moving average of $553.76. The company has a market cap of $451.28 billion, a PE ratio of 31.83, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the firm posted $5.83 earnings per share. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be paid a $2.10 dividend. The ex-dividend date is Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.70%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.33% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on UNH shares. Barclays cut their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Oppenheimer upped their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. KeyCorp reissued an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Piper Sandler cut their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Finally, Stephens raised their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.